Literature DB >> 6122056

Susceptibility of Plasmodium falciparum to pyrimethamine and sulfadoxine/pyrimethamine in Kisumu, Kenya.

P Nguyen-Dinh, H C Spencer, S Chemangey-Masaba, F C Churchill.   

Abstract

Field studies were conducted in Kisumu, Kenya, to assess the susceptibility of local strains of Plasmodium falciparum to pyrimethamine alone (by a standard 7-day in-vivo test and a 48 h in-vitro field test) and to sulfadoxine-pyrimethamine (by a 7-day in-vivo test). Both in-vivo (10/11) and in-vitro (19/21) tests demonstrated that pyrimethamine resistance was very common. Parasite susceptibility to sulfadoxine-pyrimethamine was uniformly greater when 24 isolates were tested in vivo, thus indicating that this drug combination remains valuable despite the high frequency of resistance to pyrimethamine alone.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6122056     DOI: 10.1016/s0140-6736(82)91873-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  9 in total

1.  Plasmodium falciparum in Haiti: susceptibility to pyrimethamine and sulfadoxine-pyrimethamine.

Authors:  P Nguyen-Dinh; A Zevallos-Ipenza; R Magloire
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

Review 2.  Chemoprophylaxis of malaria in Africa: the spent "magic bullet".

Authors:  L J Bruce-Chwatt
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-11

3.  Comparison of chloroquine, pyrimethamine and sulfadoxine, and chlorproguanil and dapsone as treatment for falciparum malaria in pregnant and non-pregnant women, Kakamega District, Kenya.

Authors:  M Keuter; A van Eijk; M Hoogstrate; M Raasveld; M van de Ree; W A Ngwawe; W M Watkins; J B Were; A D Brandling-Bennett
Journal:  BMJ       Date:  1990-09-08

Review 4.  Recent advances in malaria parasite cultivation and their application to studies on host-parasite relationships: a review.

Authors:  P I Trigg
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

5.  Serial studies on the evolution of chloroquine resistance in an area of East Africa receiving intermittent malaria chemosuppression.

Authors:  C C Draper; G Brubaker; A Geser; V A Kilimali; W H Wernsdorfer
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

6.  The problem of Plasmodium falciparum drug resistance in Africa south of the Sahara.

Authors:  E Onori
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

7.  Differences in selective pressure on dhps and dhfr drug resistant mutations in western Kenya.

Authors:  Andrea M McCollum; Kristan A Schneider; Sean M Griffing; Zhiyong Zhou; Simon Kariuki; Feiko Ter-Kuile; Ya Ping Shi; Laurence Slutsker; Altaf A Lal; Venkatachalam Udhayakumar; Ananias A Escalante
Journal:  Malar J       Date:  2012-03-22       Impact factor: 2.979

8.  Chemosensitization of Plasmodium falciparum by probenecid in vitro.

Authors:  Alexis Nzila; Eddy Mberu; Pat Bray; Gilbert Kokwaro; Peter Winstanley; Kevin Marsh; Steve Ward
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

Review 9.  Anti-malarial treatment outcomes in Ethiopia: a systematic review and meta-analysis.

Authors:  Eyob Alemayehu Gebreyohannes; Akshaya Srikanth Bhagavathula; Mohammed Assen Seid; Henok Getachew Tegegn
Journal:  Malar J       Date:  2017-07-03       Impact factor: 2.979

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.